2025-10-30 - Analysis Report
Okay, here's an analysis of Waste Management Inc. (WM) based on the information you provided. I'll present the analysis in English, starting with the key numbers and followed by more detailed explanations.

## Waste Management Inc. (WM) Analysis

**Company Overview:** Waste Management Inc. is a leading provider of comprehensive waste management services in North America.

### 1. Performance vs. S&P 500 (VOO)

*   **WM Cumulative Return:** 81.88%
*   **VOO Cumulative Return:** 104.04%
*   **Cumulative Return Difference:** -22.16% (WM is lagging S&P 500)
*   **Historical Divergence:**
    *   Max: 73.4
    *   Min: -9.6
    *   Current: -3.5
    *   Relative Divergence: 7.3 (WM is currently positioned at the 7.3rd percentile of its historical divergence range relative to the S&P 500.)

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha | Beta | Cap(B) |
| :----------- | :------ | :----- | :---- | :--- | :----- |
| 2015-2017  | 47.0%   | 66.7%  | 19.0% | 0.0  | 34.8   |
| 2016-2018  | 39.0%   | 69.9%  | 24.0% | 0.0  | 35.8   |
| 2017-2019  | 36.0%   | 69.9%  | 13.0% | 0.2  | 45.9   |
| 2018-2020  | 15.0%   | 81.4%  | -9.0% | 0.2  | 47.5   |
| 2019-2021  | 54.0%   | 81.4%  | 7.0%  | 0.3  | 67.2   |
| 2020-2022  | 19.0%   | 81.4%  | 19.0% | 0.3  | 63.2   |
| 2021-2023  | 52.0%   | 81.0%  | 50.0% | 0.2  | 72.1   |
| 2022-2024  | 23.0%   | 81.0%  | 3.0%  | 0.2  | 81.2   |
| 2023-2025  | -5.0%   | 71.5%  | -73.0% | 0.1  | 80.6   |

**Analysis:**

*   **Underperformance:** WM has underperformed the S&P 500 over the period analyzed, with a cumulative return difference of -22.16%.
*   **Relative Divergence:** The current relative divergence of 7.3 suggests that WM is trading closer to the lower end of its historical divergence range compared to the S&P 500.
*   **Alpha/Beta:** The Alpha/Beta analysis shows varying performance across different periods.  Recent years (2023-2025) show a negative alpha, indicating underperformance relative to the market, while beta remains relatively low, suggesting lower volatility compared to the market.  The negative alpha in the 2023-2025 period is significant, indicating substantial underperformance.
*   **CAGR/MDD:** The CAGR (Compound Annual Growth Rate) varies considerably across the periods. MDD(Maximum Drawdown) represents the largest peak-to-trough decline during a specific period. The MDD remains high, reflecting potential volatility and risk.

### 2. Recent Price Action

*   **Current Price:** 200.23
*   **Last Market Data:**
    *   Price: 199.985
    *   Previous Close: 204.23
    *   Change: -2.08
*   **Moving Averages:**
    *   5-day MA: 212.246
    *   20-day MA: 215.9887
    *   60-day MA: 221.1

**Analysis:**

*   **Price Decline:** The price has decreased recently, as indicated by the negative change in the last market data.
*   **Moving Averages:** The current price is below all three moving averages (5, 20, and 60-day), suggesting a short-term and potentially intermediate-term downtrend.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 16.31 (Oversold)
*   **PPO:** -0.4479
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)
*   **Delta_Previous_Relative_Divergence:** -6.8 (Negative, Short-term Decline)
*   **Expected Return:** 638.8% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** A high MRI of 0.9 suggests that the overall market conditions are favorable for investment, though this is a general market indicator and not specific to WM.
*   **RSI:** The extremely low RSI indicates that the stock is significantly oversold, potentially suggesting a buying opportunity.
*   **PPO:**  The negative PPO value indicates that the short-term moving average is below the long-term moving average, suggesting a downtrend.
*   **Hybrid Signal:** This is a model-driven recommendation suggesting to invest available cash and continue monthly investments.  The signal considers the MRI and suggests a "Very Safe" investment profile.
*   **Delta_Previous_Relative_Divergence:**  The negative change in relative divergence confirms the recent short-term underperformance compared to the S&P 500.
*   **Expected Return:** The very high expected return (638.8%) is a significant claim. It represents the projected long-term outperformance relative to the S&P 500 if a consistent investment strategy is followed.  This figure should be viewed with caution, as such high returns are unlikely to be guaranteed.
*   **Significant Price Change:** The last market data shows a notable change of -2.08, indicating a recent downward pressure on the stock price.

### 4. Recent News & Significant Events

*   **Price Target Adjustments:** Several analysts have adjusted their price targets for Waste Management. RBC and Baird lowered their targets, while Scotiabank adjusted its target slightly down, and Citigroup slightly up, while maintaining their ratings.
*   **Margin Pressures & Healthcare Integration:**  One article discusses margin pressures and the impact of healthcare integration on the company's outlook.
*   **Monthly Dip Analysis:** An article questions whether the recent monthly dip is a signal or a short-term setback.

**Analysis:**

*   **Mixed Analyst Sentiment:** Analyst opinions are mixed, with some lowering price targets while others maintain or slightly increase them.  The presence of "Buy," "Sector Outperform," "Sector Perform," and "Neutral" ratings suggest a lack of strong consensus.
*   **Key Issues:** Margin pressures and the integration of healthcare services appear to be significant factors influencing the company's performance and analyst outlook.
*   **Market Uncertainty:** The article questioning the recent dip reflects uncertainty among investors regarding the stock's near-term prospects.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean: 2.00)
*   **Opinions:** 22
*   **Target Price:**
    *   Average: 246.55
    *   High: 270.00
    *   Low: 198.00
*   **Recent Rating Changes:** No recent rating changes are specified.

**Analysis:**

*   **Buy Recommendation:** The analyst consensus leans towards a "Buy" recommendation.
*   **Target Price Range:** The average target price suggests potential upside from the current price. However, the range between the high and low targets indicates some disagreement among analysts.

### 5. Recent Earnings Analysis

| 날짜         | EPS   | 매출          |
| :----------- | :---- | :------------ |
| 2025-08-29 | 0.88  | 175.75 B$     |
| 2025-06-06 | 0.56  | 163.98 B$     |
| 2024-12-06 | 0.57  | 168.00 B$     |
| 2024-08-30 | 0.56  | 167.77 B$     |
| 2025-08-29 | 0.56  | 167.77 B$     |

**Analysis:**

*   **Recent EPS Increase:** The most recent EPS (2025-08-29) is significantly higher than previous quarters.
*   **Revenue Growth:** Revenue appears to be growing, with the latest figure being the highest in the provided data.
*   **Inconsistency:** There is duplicate data for 2025-08-29, which needs verification.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-06-30 | $6.43B    | 40.30%        |
| 2025-03-31 | $6.02B    | 39.40%        |
| 2024-12-31 | $5.89B    | 39.71%        |
| 2024-09-30 | $5.61B    | 39.40%        |
| 2024-06-30 | $5.40B    | 39.08%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
| :----------- | :-------- | :------ |
| 2025-06-30 | $9.20B    | 7.89%   |
| 2025-03-31 | $8.65B    | 7.36%   |
| 2024-12-31 | $8.25B    | 7.25%   |
| 2024-09-30 | $7.98B    | 9.53%   |
| 2024-06-30 | $7.46B    | 9.12%   |

**Analysis:**

*   **Revenue Growth:** Revenue has been consistently increasing over the past five quarters.
*   **Stable Profit Margin:** The profit margin has remained relatively stable, hovering around 39-40%.
*   **Equity Growth:** Equity has also been growing, indicating a strengthening financial position.
*   **ROE Decline:** ROE (Return on Equity) has decreased in recent quarters, which could be a concern.

### 7. 종합적인 분석 (Overall Analysis)

Based on the information provided, here's a summary of the key takeaways:

*   **Underperformance vs. S&P 500:** WM has underperformed the S&P 500 over the analyzed period.  The recent negative delta in relative divergence suggests continued short-term underperformance.
*   **Recent Price Weakness:** The stock price has been declining recently and is trading below key moving averages. The last market data confirms a recent downward pressure.
*   **Oversold Condition:** The RSI indicates that the stock is oversold, which could present a potential buying opportunity.
*   **Mixed Analyst Sentiment:** Analyst opinions are mixed, with some lowering price targets due to concerns about margin pressures and healthcare integration. However, the consensus remains a "Buy" recommendation with an average target price above the current price.
*   **Solid Financials:** The company has demonstrated consistent revenue and equity growth, with stable profit margins. However, the recent decline in ROE warrants monitoring.
*   **High Expected Return (Caveat):** The projected long-term return is very high but should be considered with skepticism.
*   **The hybrid signal:** recommends to invest available cash and continue monthly investments

**Overall Recommendation:**

The analysis presents a mixed picture. While the company exhibits strong financial performance and a buy rating from analysts, it has recently underperformed the S&P 500, and the stock price is currently on a downtrend.

The recent price decline and oversold condition might present a buying opportunity for long-term investors, especially given the solid financials. However, the concerns about margin pressures and healthcare integration should be carefully considered. Investors should closely monitor the company's performance in the coming quarters to assess whether it can address these challenges and improve its relative performance.

In conclusion, this is a complex situation. Consider your risk tolerance, investment horizon, and perform further due diligence before making any investment decisions.
